REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 7.50 (1.80%)
Spread: 10.00 (2.381%)
Open: 417.50
High: 425.00
Low: 417.50
Prev. Close: 417.50
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Exterran UK

4 Jul 2013 07:00

AVINGTRANS PLC - Acquisition of Exterran UK

AVINGTRANS PLC - Acquisition of Exterran UK

PR Newswire

London, July 3

4th July 2013 Avingtrans plc ("Avingtrans", "Group" or "the Company") Acquisition of Exterran UK Avingtrans plc, which designs, manufactures and supplies critical componentsand associated services to the global aerospace, energy, and medical sectors,announces that it has acquired the entire issued share capital of Exterran (UK)Ltd. ("Exterran UK"), the UK operations of US-based Exterran for a totalconsideration of £1 (the "Acquisition"). The principal activity of the acquired business, which is based in Walsall, isthe design, fabrication and installation of products for the global oil and gasmarket, including equipment solutions for petroleum production, gas processing,produced water treatment and aftermarket parts and services. The business hastraded in the UK for many years and has been a long standing customer ofMetalcraft. The business, which employs 85 people, will be integrated into theEnergy and Medical division of Avingtrans. This new part of the division willhenceforth be known as Maloney Metalcraft Ltd, to reinvigorate a previouslywell-known brand name in this market sector. Its key customers include:Petrofac, Talisman, Porvair, EDF and Shell. The Board believes that the Acquisition complements the existing capabilitieswithin its energy offering and will provide cross selling opportunities. Itwill also enable the Company to pitch for larger projects once the Acquisitionis fully integrated. The Board believes that the experience and capability ofthe Exterran UK engineering team will provide additional expertise asAvingtrans looks to increase its product offering and grow the division. In the financial year ended 31 December 2012, Exterran UK reported revenue of £16.3 million and an adjusted loss before tax of £0.5m (which includes anadjustment for the removal of a loss making contract which was novatedfollowing the year end). Exterran UK is being acquired with a cash balance of £2 million, which management believes will be sufficient to fund the turnaroundof the business, and on completion is expected to have net assets of circa £1.2million. The Company expects Exterran UK to be at least break even in the yearending 31 May 2015 and earnings enhancing thereafter. (1). Steve McQuillan, Chief Executive of Avingtrans commented: "We are pleased to announce the acquisition of Exterran UK which has a strongpedigree. This addition to the Avingtrans Group reinforces our plan to buildthe business around our two core divisions; Metalcraft (Energy and Medical) andSigma (Aerospace) and provides scale and expertise in the attractive Energymarketplace. We are delighted that they will be joining the Group and areconfident of our combined future success." -ends- Avingtrans plc Tel: 01159 499 020Steve McQuillan, Chief Executive OfficerStephen King, Finance Director Numis (Nominated Advisor & Broker) Tel: 020 7260 1000David Poutney (Corporate Broking)Richard Thomas (Corporate Finance and Nominated Adviser) Newgate Threadneedle(Financial PR) Tel: 020 7653 9850Josh Royston Heather Armstrong 1. No statement in this announcement is intended as a profit forecast or estimate for any period and no statement in this announcement should be interpreted to mean that earnings or earnings per ordinary share for the Company, for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per ordinary share.
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.